Adaptive Metabolic and Inflammatory Responses Identified Using Accelerated Aging Metrics Are Linked to Adverse Outcomes in Severe SARS-CoV-2 Infection
Author(s) -
Alejandro MárquezSalinas,
Carlos A. FermínMartínez,
Neftalí Eduardo Antonio-Villa,
Arsenio VargasVázquez,
Enrique C. Guerra,
Alejandro Campos-Muñoz,
Lilian ZavalaRomero,
Roopa Mehta,
Jessica Paola Bahena-López,
Edgar OrtízBrizuela,
María Fernanda González-Lara,
Carla M. RománMontes,
Bernardo Alfonso Martínez-Guerra,
Alfredo PoncedeLeón,
José SifuentesOsornio,
Luis Miguel GutiérrezRobledo,
Carlos A. AguilarSalinas,
Omar Yaxmehen BelloChavolla
Publication year - 2021
Publication title -
the journals of gerontology series a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.134
H-Index - 189
eISSN - 1758-535X
pISSN - 1079-5006
DOI - 10.1093/gerona/glab078
Subject(s) - medicine , adverse effect , intensive care unit , retrospective cohort study , cohort , proportional hazards model , severity of illness , intensive care medicine
Chronological age (CA) is a predictor of adverse coronavirus disease 2019 (COVID-19) outcomes; however, CA alone does not capture individual responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Here, we evaluated the influence of aging metrics PhenoAge and PhenoAgeAccel to predict adverse COVID-19 outcomes. Furthermore, we sought to model adaptive metabolic and inflammatory responses to severe SARS-CoV-2 infection using individual PhenoAge components.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom